poLight ASA today announced that Transcend Vivoscope, a leader in biomedical imaging, will debut the SUPERNOVA-600, their latest miniature turnkey solution of two-photon microscopy (mTPM), at the Neuroscience 2024 conference in Chicago, Illinois, Oct. 5-9. The SUPERNOVA-600 incorporates TLens tunable optics for real-time optimal microscopic in vivo imaging of neuronal and cellular activities in the brain, advancing research in cognition, drug development, and diseases including Alzheimer’s, Parkinson’s, epilepsy, and others.
“The SUPERNOVA-600, our latest flagship product, offers flexible and diverse combination configurations,” said Dr. Wu Runlong, Director of R&D at Transcend Vivoscope. “It allows for the real-time synchronization of microscopic neuronal and synaptic activity with the overall information processing of the brain and individual behaviours, providing a panoramic analysis of connectomes and functional dynamic maps.
This technology ensures more efficient, stable, and continuous output of high-quality data, offering researchers an ideal comprehensive solution for free-moving animal imaging. The low-power, fast, autofocus capabilities of the TLens enable rapid and precise focal adjustments, ensuring optimal imaging quality. We look forward to leveraging TLens in our full SUPERNOVA product portfolio.”
“Following the Kavli Institute’s use of TLens in their miniature two-photon innovation and subsequent Nobel Prize, we have seen strong interest in this unique device from many research groups around the world,” said Dr. Oyvind Isaksen, CEO of poLight ASA. “We are excited to see another commercial player supplying the tools and resources to accelerate the deployment of mTPM systems, and we look forward to a long-term relationship with Transcend Vivoscope.”
Following the successful debut of the SUPERNOVA-100, a compact mTPM imaging system, during Neuroscience 2023, Transcend Vivoscope will exhibit the entire SUPERNOVA family in booth #357 at the Neuroscience 2024 conference.
